Stockscreener 앱 받기
2.96
7.21%
-0.23
시간 외 거래:
2.95
-0.010
-0.34%
전일 마감가:
$3.19
열려 있는:
$3.12
하루 거래량:
837.51K
Relative Volume:
0.34
시가총액:
$142.99M
수익:
-
순이익/손실:
$-97.22M
주가수익비율:
-2.1449
EPS:
-1.38
순현금흐름:
$-82.44M
1주 성능:
-17.32%
1개월 성능:
-18.46%
6개월 성능:
+83.85%
1년 성능:
-88.54%
1일 변동 폭
$2.96
$3.1499
1주일 범위
$2.96
$3.56
52주 변동 폭
$1.15
$33.98
카사바 Stock (SAVA) Company Profile
명칭
Cassava Sciences Inc
전화
512-501-2444
주소
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
SAVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.96 | 154.10M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
카사바 Stock (SAVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-27 | 개시 | B. Riley Securities | Buy |
| 2021-02-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-01-10 | 재확인 | Maxim Group | Buy |
모두보기
카사바 주식(SAVA)의 최신 뉴스
Why Cassava Sciences Inc. (PX91) stock appeals to dividend investorsShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
Is Cassava Sciences Inc. stock a defensive play in 2025Portfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
Will Cassava Sciences Inc. continue its uptrend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
Why Cassava Sciences Inc. Equity Warrant is moving todayTrend Reversal & Consistent Growth Stock Picks - newser.com
Is Cassava Sciences Inc. Equity Warrant stock bottoming outMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
Why Cassava Sciences Inc. is moving todayQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Will Cassava Sciences Inc. Equity Warrant stock benefit from green energy trendsJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
Multi asset correlation models including Cassava Sciences Inc. Equity Warrant2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Will Cassava Sciences Inc. stock go up soonTrade Entry Report & High Accuracy Trade Alerts - newser.com
Chart overlay techniques for tracking Cassava Sciences Inc.July 2025 Outlook & Growth Focused Entry Reports - newser.com
Why Cassava Sciences Inc. stock is in analyst buy zone2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Can Cassava Sciences Inc. stock attract ESG capital inflowsTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why Cassava Sciences Inc. stock is favored by pension fundsTrade Volume Summary & Technical Pattern Based Signals - newser.com
How institutional ownership impacts Cassava Sciences Inc. Equity Warrant stock - newser.com
Can RSWM Limited Maintain Its Share of Global Market for Its ProductVolume Spike Alerts & Achieve Explosive Results - earlytimes.in
Why analysts upgrade Cassava Sciences Inc. stockJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Can Cassava Sciences Inc. Equity Warrant stock maintain operating marginsBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Tools to monitor Cassava Sciences Inc. Equity Warrant recovery probabilityDay Trade & AI Enhanced Execution Alerts - newser.com
What risks investors should watch in Cassava Sciences Inc. stock2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Full technical analysis of Cassava Sciences Inc. stock2025 Macro Impact & Short-Term High Return Strategies - newser.com
What analyst consensus says on Cassava Sciences Inc. stockJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - newser.com
Is it too late to sell Cassava Sciences Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Cassava Sciences Inc. Equity Warrant stock volume spike explainedEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Will Cassava Sciences Inc. Equity Warrant stock deliver shareholder valueBear Alert & Daily Stock Trend Watchlist - newser.com
How currency fluctuations impact Cassava Sciences Inc. stockJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
Why Cassava Sciences Inc. (PX91) stock could be next leaderLayoff News & Accurate Intraday Trading Signals - newser.com
Is Cassava Sciences Inc. stock a buy on dipsGDP Growth & Weekly Market Pulse Alerts - newser.com
Risk adjusted return profile for Cassava Sciences Inc. analyzedMarket Trend Summary & Daily Momentum Trading Reports - newser.com
Is Cassava Sciences Inc. Equity Warrant stock affected by interest rate hikesAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Will Cassava Sciences Inc. Equity Warrant stock keep outperforming rivalsJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com
What to expect from Cassava Sciences Inc. in the next 30 daysPortfolio Risk Report & Daily Chart Pattern Signal Reports - newser.com
Will Cassava Sciences Inc. Equity Warrant stock benefit from sector rotationM&A Rumor & Verified Swing Trading Watchlists - newser.com
Why Cassava Sciences Inc. Equity Warrant stock is a value investor pickM&A Rumor & Stock Portfolio Risk Control - newser.com
Can Cassava Sciences Inc. (PX91) stock ride next bull market cycleSell Signal & Technical Analysis for Trade Confirmation - newser.com
카사바 (SAVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):